{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:07:16Z","timestamp":1777349236005,"version":"3.51.4"},"reference-count":38,"publisher":"Cambridge University Press (CUP)","issue":"8","license":[{"start":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T00:00:00Z","timestamp":1412208000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Gonorrhoea is one of the most common sexually transmitted infections. The control of gonorrhoea is extremely challenging because of the repeated development of resistance to the antibiotics used for its treatment. We explored different strategies to control the spread of antimicrobial resistance and prevent increases in gonorrhoea prevalence. We used a mathematical model that describes gonorrhoea transmission among men who have sex with men and distinguishes gonorrhoea strains sensitive or resistant to three antibiotics. We investigated the impact of combination therapy, switching first-line antibiotics according to resistance thresholds, and other control efforts (reduced sexual risk behaviour, increased treatment rate). Combination therapy can delay the spread of resistance better than using the 5% resistance threshold. Increased treatment rates, expected to enhance gonorrhoea control, may reduce gonorrhoea prevalence only in the short term, but could lead to more resistance and higher prevalence in the long term. Re-treatment of resistant cases with alternative antibiotics can substantially delay the spread of resistance. In conclusion, combination therapy and re-treatment of resistant cases with alternative antibiotics could be the most effective strategies to prevent increases in gonorrhoea prevalence due to antimicrobial resistance.<\/jats:p>","DOI":"10.1017\/s0950268814002519","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T14:21:09Z","timestamp":1412259669000},"page":"1575-1584","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":27,"title":["Public health measures to control the spread of antimicrobial resistance in<i>Neisseria gonorrhoeae<\/i>in men who have sex with men"],"prefix":"10.1017","volume":"143","author":[{"given":"M.","family":"XIRIDOU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. C.","family":"SOETENS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. D. H.","family":"KOEDIJK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A. B.","family":"VAN DER SANDE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"WALLINGA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,10,2]]},"reference":[{"key":"S0950268814002519_ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks162"},{"key":"S0950268814002519_ref34","first-page":"422","article-title":"Gonorrhoea in men: clinical and diagnostic aspects","volume":"72","author":"Sherrard","year":"1996","journal-title":"Genitourinary Medicine"},{"key":"S0950268814002519_ref30","article-title":"Gonococci change faster than prescription-behaviour","volume":"157","author":"Koedijk","year":"2013","journal-title":"Nederlands Tijdschrift van Geneeskunde"},{"key":"S0950268814002519_ref29","volume-title":"Guidelines for the Management of Sexually Transmitted Diseases","year":"2003"},{"key":"S0950268814002519_ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000578"},{"key":"S0950268814002519_ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0020137"},{"key":"S0950268814002519_ref7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05760-11"},{"key":"S0950268814002519_ref37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2002.03173.x"},{"key":"S0950268814002519_ref27","unstructured":"Schorer Foundation. Schorer Monitor 2006, 2007, 2008, 2009, 2010, 2011."},{"key":"S0950268814002519_ref26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-436"},{"key":"S0950268814002519_ref32","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112597"},{"key":"S0950268814002519_ref10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.22.12106"},{"key":"S0950268814002519_ref3","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2009.037135"},{"key":"S0950268814002519_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70693-5"},{"key":"S0950268814002519_ref4","unstructured":"Health Protection Agency. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) 2011 Report. HPA Gateway reference: HPA12\u201303. London, 2012."},{"key":"S0950268814002519_ref12","doi-asserted-by":"publisher","DOI":"10.1136\/sti.78.suppl_1.i20"},{"key":"S0950268814002519_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulm.2003.11.006"},{"key":"S0950268814002519_ref21","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1997.0227"},{"key":"S0950268814002519_ref22","volume-title":"Lecture Notes in Biomathematics","author":"Heathcote","year":"1984"},{"key":"S0950268814002519_ref5","first-page":"590","article-title":"Update to CDC's sexually transmitted diseases treatment guidelines, 2010; Oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","year":"2012","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268814002519_ref28","unstructured":"National Institute of Public Health and the Environment. Sexually transmitted infections, including HIV, in the Netherlands in 2011. RIVM report no. 201051001. Bilthoven, The Netherlands, 2012."},{"key":"S0950268814002519_ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg136"},{"key":"S0950268814002519_ref1","unstructured":"World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. 2012 (http:\/\/whqlibdoc.who.int\/publications\/2012\/9789241503501_eng.pdf)."},{"key":"S0950268814002519_ref2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.042648"},{"key":"S0950268814002519_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2011.03.008"},{"key":"S0950268814002519_ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030124"},{"key":"S0950268814002519_ref24","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02311-05"},{"key":"S0950268814002519_ref8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-11"},{"key":"S0950268814002519_ref20","first-page":"187","article-title":"Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance","volume":"2","author":"Lipsitch","year":"1998","journal-title":"International Journal Tuberculosis Lung Diseases"},{"key":"S0950268814002519_ref14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00711-13"},{"key":"S0950268814002519_ref38","doi-asserted-by":"publisher","DOI":"10.1214\/11-AOAS488"},{"key":"S0950268814002519_ref36","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/genetics\/156.4.1471","article-title":"Compensatory evolution in rifampin-resistant Escherichia coli","volume":"156","author":"Reynolds","year":"2000","journal-title":"Genetics"},{"key":"S0950268814002519_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-002-0204-8"},{"key":"S0950268814002519_ref15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.4.1938"},{"key":"S0950268814002519_ref33","volume-title":"Sexually Transmitted Disease","author":"Hook","year":"1990"},{"key":"S0950268814002519_ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1001094"},{"key":"S0950268814002519_ref11","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050049"},{"key":"S0950268814002519_ref23","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.1999.0431"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268814002519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T19:00:09Z","timestamp":1650308409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268814002519\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,2]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0950268814002519"],"URL":"https:\/\/doi.org\/10.1017\/s0950268814002519","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,2]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2014\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}